Governance
ESG at Imagene
1. Our Approach to ESG
Imagene develops and provides AI-powered pathology and multimodal biomarker solutions for biopharmaceutical research, clinical development and diagnostics. Our approach to environmental, social and governance (ESG) matters reflects the responsibilities associated with our technology, our use of sensitive data, our scientific and clinical activities, and our relationships with employees, customers and business partners.
We aim to integrate responsible practices into our operations and decision-making in a way that is proportionate to our activities and stage of development. This includes protecting information, developing and using AI responsibly, supporting scientific integrity and patient safety, fostering a respectful workplace, and managing our environmental impacts.
2. Our Material ESG Topics
Imagene conducted an initial materiality assessment to identify ESG topics relevant to its business and activities. The process began with a peer benchmarking review of companies operating in AI, digital pathology and precision oncology, examining the ESG topics addressed in their public disclosures.
The topics identified through the benchmarking exercise were reviewed internally to assess their relevance to Imagene’s operations and business context. Following this review, the Company approved the material ESG topics presented below as the focus of its ESG approach.
We will review these topics periodically as our activities evolve. As our approach develops, we aim to strengthen the assessment by further evaluating the significance of our actual and potential impacts on people, the environment and the economy, including human rights, and incorporating relevant stakeholder perspectives, guided by the GRI Standards.
2.1 Data Privacy and Protection
Our activities involve personal, clinical, research and business information. Protecting this information is essential to safeguarding individuals’ privacy and rights, maintaining confidentiality and supporting the integrity and availability of our services.
Imagene maintains an information security management system certified to ISO/IEC 27001:2022 and ISO 27799. Our safeguards include access controls, encryption, security monitoring, incident response and business continuity arrangements.
We aim to maintain and strengthen these safeguards as our systems and activities evolve, taking account of applicable legal, regulatory and contractual requirements throughout the information lifecycle.
2.2 Responsible AI
The development and use of AI can influence research findings, biomarker assessment and clinical workflows. We recognise the importance of evaluating model performance and limitations for intended uses, including potential bias and differences in performance across relevant populations and datasets.
Our approach to responsible AI is guided by appropriate data governance, scientific evaluation, documentation, traceability and human oversight. These principles support the responsible development, interpretation and use of our technologies.
2.3 Product and Service Quality
The quality and reliability of our products and services can affect research conclusions and, where used in clinical settings, decisions relevant to patient care. Scientific and clinical integrity are therefore central to our work in precision oncology.
We seek to support quality and reliability through development, validation, review and documentation practices appropriate to each solution’s intended use and applicable requirements. We distinguish research applications from clinical uses and seek to ensure that claims about our technologies are supported by appropriate evidence.
As our activities evolve, we aim to strengthen these practices while maintaining patient safety, scientific integrity and quality as central considerations in product, service and operational decisions.
2.4 Business Ethics, Compliance and Reporting Channels
Ethical conduct supports trust in our work and our relationships with employees, customers, research collaborators, suppliers and other business partners. We are committed to conducting business honestly and responsibly and complying with applicable laws and contractual obligations.
Our ethical commitments include preventing bribery and corruption, managing conflicts of interest, protecting confidential information and promoting fair and responsible business relationships.
Employees are expected to follow our Code of Ethics and Conduct and raise concerns through the reporting channels identified in it. We are committed to the appropriate review and handling of concerns and to protecting those who report in good faith from retaliation.
2.5 Employee Development and Wellbeing
Our employees are central to Imagene’s work. We are committed to fair working conditions and a respectful, safe and supportive working environment.
We aim to support professional learning and development, promote employee wellbeing and maintain appropriate occupational health and safety practices. These practices should reflect the different needs and risks associated with our office, laboratory and technology-related activities.
As the Company grows, we aim to strengthen and further structure these practices, taking account of employee feedback, evolving organisational needs and applicable requirements.
2.6 Diversity, Inclusion and Human Rights
Imagene is committed to respecting human rights, promoting equal opportunity and preventing discrimination and harassment. We aim to foster an inclusive workplace in which people from diverse backgrounds are treated with dignity and respect.
We seek to provide fair access to employment, learning and career development opportunities. Decisions concerning recruitment, development and promotion should be based on relevant qualifications, skills, experience and role requirements, without unlawful discrimination.
We recognise that human rights considerations are also relevant to our relationships with contractors, suppliers and other business partners. As we develop our procurement and supplier review processes, we aim to incorporate these considerations in a manner proportionate to the activities and risks involved.
2.7 Environment and Climate
Imagene recognises the environmental impacts associated with its computing infrastructure, laboratory activities, workplaces and supply chain. We are committed to reducing greenhouse gas emissions, using resources responsibly and improving our environmental practices.
Our approach focuses on efficient computing and energy use, responsible purchasing and business travel, water conservation, equipment reuse and waste reduction. We also consider climate-related risks to our operations and infrastructure. These efforts must remain consistent with scientific integrity, patient safety, quality, information security and applicable data requirements.
We are committed to reducing our aggregate Scope 1, Scope 2 and Scope 3 greenhouse gas emissions per unit of supply by at least 50% by 31 December 2030, using 2025 as the baseline year. This is an emissions-intensity target rather than an absolute emissions reduction target. To measure progress, we will establish and maintain an annual emissions inventory, compile emissions data for the baseline year and define a consistent methodology for measuring emissions per unit of supply, in line with applicable contractual requirements.
We are also committed to setting near-term science-based emissions reduction targets through the Science Based Targets initiative (SBTi), using the appropriate route based on our eligibility and meeting applicable contractual deadlines. We will report our progress accurately and will not describe targets as SBTi-validated unless validation has been obtained.
3. Governance and Accountability
Company management oversees Imagene’s ESG approach. We will appoint an internal coordinator and assign responsibilities across the relevant teams to support implementation.
Each team will contribute within its area of responsibility through relevant policies, operational practices and improvement actions. Management will periodically review priorities and progress, taking account of applicable legal and contractual requirements.
4. Next Steps
Our ESG measurement approach is at an early stage. As Imagene grows, we aim to develop relevant indicators, establish data collection processes and compile baseline information for our material ESG topics. We will communicate progress as reliable information becomes available, distinguishing between planned actions and measured results.
Our priorities include establishing an annual greenhouse gas emissions inventory, progressing our SBTi commitments, and obtaining and maintaining a valid EcoVadis scorecard within applicable contractual timeframes. We will use the EcoVadis assessment findings to prioritise improvements across environmental management, labour and human rights, ethics, and sustainable procurement.
We intend to use relevant GRI Standards to guide the development of our ESG reporting approach. We will review this document periodically to reflect changes in our activities, priorities and reporting capabilities.